Rajdeepsingh Waghela, MD (he/him/his)

Houston Methodist Hospital

Poster(s):

• P4313 - Predictors and Outcomes of Requiring Change of Therapy to Risankizumab, Upadacitnib, or Combination Therapy in Patients with Crohn’s Disease
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET